CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 144 filers reported holding CASSAVA SCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,065,818 | -26.9% | 1,025,590 | +7.7% | 0.00% | 0.0% |
| Q2 2023 | $23,345,124 | -8.6% | 952,085 | -10.1% | 0.00% | 0.0% |
| Q1 2023 | $25,541,804 | -56.5% | 1,058,949 | -46.7% | 0.00% | -50.0% |
| Q4 2022 | $58,728,238 | +40.8% | 1,988,092 | +99.4% | 0.00% | -33.3% |
| Q3 2022 | $41,705,000 | +48.3% | 997,249 | -0.3% | 0.00% | +50.0% |
| Q2 2022 | $28,122,000 | -28.2% | 1,000,068 | -5.1% | 0.00% | 0.0% |
| Q1 2022 | $39,144,000 | -8.2% | 1,053,956 | +8.0% | 0.00% | 0.0% |
| Q4 2021 | $42,657,000 | -26.8% | 976,126 | +3.9% | 0.00% | -33.3% |
| Q3 2021 | $58,298,000 | -21.6% | 939,086 | +8.0% | 0.00% | -25.0% |
| Q2 2021 | $74,322,000 | +140.9% | 869,878 | +26.7% | 0.00% | +100.0% |
| Q1 2021 | $30,850,000 | +908.5% | 686,310 | +53.0% | 0.00% | – |
| Q4 2020 | $3,059,000 | -24.6% | 448,552 | +27.2% | 0.00% | – |
| Q3 2020 | $4,057,000 | +461.1% | 352,502 | +50.2% | 0.00% | – |
| Q2 2020 | $723,000 | – | 234,706 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
| SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
| Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
| Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
| Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
| Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
| Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
| ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
| Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |